Evidence map›Paper›PMID 37249215›Full record

ArticleeLife2023

Prolonged nicotine exposure reduces aversion to the drug in mice by altering nicotinic transmission in the interpeduncular nucleus.

Sarah Mondoloni, Claire Nguyen, Eléonore Vicq, Maria Ciscato, Joachim Jehl, Romain Durand-de Cuttoli, Nicolas Torquet, Stefania Tolu, Stéphanie Pons, Uwe Maskos and 3 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Disruption ofiScience · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Sarah MondoloniSorbonne Université, Inserm, CNRS, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris, France.ORCID 0000-0002-6134-3715
Claire NguyenSorbonne Université, Inserm, CNRS, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris, France.ORCID 0000-0002-0347-3626
Eléonore VicqSorbonne Université, Inserm, CNRS, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris, France.
Maria CiscatoBrain Plasticity Unit, CNRS, ESPCI Paris, PSL Research University, Paris, France.
Joachim JehlSorbonne Université, Inserm, CNRS, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris, France.ORCID 0000-0001-9821-7619
Romain Durand-de CuttoliSorbonne Université, Inserm, CNRS, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris, France.
Nicolas TorquetSorbonne Université, Inserm, CNRS, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris, France.ORCID 0000-0001-9032-193X
Stefania ToluSorbonne Université, Inserm, CNRS, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris, France.
Stéphanie PonsInstitut Pasteur, Unité Neurobiologie intégrative des systèmes cholinergiques, Département de neuroscience, Paris, France.
Uwe MaskosInstitut Pasteur, Unité Neurobiologie intégrative des systèmes cholinergiques, Département de neuroscience, Paris, France.
Fabio MartiSorbonne Université, Inserm, CNRS, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris, France.
Philippe Faure *Sorbonne Université, Inserm, CNRS, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris, France.ORCID 0000-0003-3573-4971
Alexandre Mourot *Sorbonne Université, Inserm, CNRS, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris, France.ORCID 0000-0002-8839-7481
Centre National de la Recherche Scientifique · FRInstitut Pasteur · FR

Funding

Agence Nationale de la Recherche ANR-17-CE16-0016 SNP-NICAgence Nationale de la Recherche ANR-21-CE16-0012 CHOLHABFondation de France Prix MédisiteFondation pour la Recherche Médicale FDT20170437427Fondation pour la Recherche Médicale FDT201904008060Fondation pour la Recherche Médicale FRM EQU201903007961Institut National Du Cancer SPA-21-002Institut National Du Cancer TABAC-16-022Institut National Du Cancer TABAC-19-02
6 · The paper itself

Abstract

Nicotine intake is likely to result from a balance between the rewarding and aversive properties of the drug, yet the individual differences in neural activity that control aversion to nicotine and their adaptation during the addiction process remain largely unknown. Using a two-bottle choice experiment, we observed considerable heterogeneity in nicotine-drinking profiles in isogenic adult male mice, with about half of the mice persisting in nicotine consumption even at high concentrations, whereas the other half stopped consuming. We found that nicotine intake was negatively correlated with nicotine-evoked currents in the interpeduncular nucleus (IPN), and that prolonged exposure to nicotine, by weakening this response, decreased aversion to the drug, and hence boosted consumption. Lastly, using knock-out mice and local gene re-expression, we identified β4-containing nicotinic acetylcholine receptors of IPN neurons as molecular and cellular correlates of nicotine aversion. Collectively, our results identify the IPN as a substrate for individual variabilities and adaptations in nicotine consumption.

Indexed as

HabenulaInterpeduncular NucleusReceptors, NicotinicAnimalsMaleMiceMice, KnockoutNeuronsNicotineNicotineReceptors, Nicotinicdrug aversionmedial habenula-interpeduncular nucleus pathwaymouseneurosciencenicotine addictionnicotinic acetylcholine receptorstwo-bottle choice paradigm

Identifiers

PMID37249215
PMCPMC10259488
OpenAlexW4378746064

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.